• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis (2100)
Event Date 03/06/2019
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the thrombectomy and lovenox that were provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since 09-oct-2017.As part of the review, it was determined that the instrument's last service was on 26-feb-2019.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint category, thrombosis.No trends were detected for this complaint category.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: thrombosis.Mc (b)(4), 04/10/2019.
 
Event Description
The customer reported that an extracorporeal photopheresis (ecp) patient experienced a bilateral deep vein thrombosis (dvt) following a treatment procedure.The customer stated that the patient's last ecp treatment procedure was on (b)(6) 2019 and this treatment used heparin as the anticoagulant at a 8:1 ratio.The customer reported that this ecp treatment procedure was successfully completed without any alarms or adverse events.The customer stated that the patient returned for their next ecp treatment procedure on (b)(6) 2019.However, the customer reported that they assessed the patient prior to starting their ecp treatment procedure due to the patient's complaints of hip pain and not feeling well.The customer stated that based on the patient's assessment, they decided to not perform the patient's ecp treatment procedure and instead the patient was admitted to the hospital on (b)(6) 2019 due to the patient's failure to thrive.The customer reported that during the patient's admission it was noted that the patient had swelling in both of her legs.The customer stated that an ultrasound was then performed which detected a dvt in both of the patient's legs.The customer reported that once the dvts were confirmed a thrombectomy was performed in order to remove the clots.The customer stated that the patient is currently on lovenox.The customer reported that the patient was still in the hospital due to failure to thrive.The customer stated that they could not rule out the patient's ecp treatment procedures as a possible contributor to the patient's dvts.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key8502272
MDR Text Key141580528
Report Number2523595-2019-00052
Device Sequence Number1
Product Code LNR
UDI-Device Identifier10705030100009
UDI-Public(01)10705030100009(11)170411
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 04/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/12/2019
Initial Date FDA Received04/10/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/11/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient Weight82
-
-